TXMD | tickerfilter.com

Fundamental analysis

42%

Profitability 25%

Dept financing 28%

Liquidity 75%

Performance 55%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

2.22%

1 Month

-5.35%

3 Months

25.00%

6 Months

107.21%

1 Year

202.00%

2 Year

3.14%

Key data

Stock price

$2.30

P/E Ratio

41.20

DAY RANGE

$2.25 - $2.35

EPS

$0.01

52 WEEK RANGE

$0.72 - $2.95

52 WEEK CHANGE

$198.86

MARKET CAP

12.442 M

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-29-2025

BETA

0.60

PUBLIC FLOAT

AVERAGE 10 VOLUME

$26,641

AVERAGE 30 VOLUME

$29,119

Company detail

CEO: Mark A. Glickman
Region: US
Website: therapeuticsmd.com
Employees: 420
IPO year: 2007

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone. It also manufactures and distributes branded and generic prescription prenatal vitamins.

TXMD - TherapeuticsMD, Inc.